| A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders R Kralovics, F Passamonti, AS Buser, SS Teo, R Tiedt, JR Passweg, ... New England Journal of Medicine 352 (17), 1779-1790, 2005 | 4670 | 2005 |
| Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients HH Hirsch, W Knowles, M Dickenmann, J Passweg, T Klimkait, ... New England Journal of Medicine 347 (7), 488-496, 2002 | 1416 | 2002 |
| Solid cancers after bone marrow transplantation RE Curtis, PA Rowlings, HJ Deeg, DA Shriner, G Socié, LB Travis, ... New England Journal of Medicine 336 (13), 897-904, 1997 | 1110 | 1997 |
| IBMTR Severity Index for grading acute graft‐versus‐host disease: retrospective comparison with Glucksberg grade PA Rowlings, D Przepiorka, JP Klein, RP Gale, JR Passweg, ... British journal of haematology 97 (4), 855-864, 1997 | 818 | 1997 |
| Long-term survival and late deaths after allogeneic bone marrow transplantation G Socié, JV Stone, JR Wingard, D Weisdorf, PJ Henslee-Downey, ... New England Journal of Medicine 341 (1), 14-21, 1999 | 805 | 1999 |
| Molecular minimal residual disease in acute myeloid leukemia M Jongen-Lavrencic, T Grob, D Hanekamp, FG Kavelaars, A Al Hinai, ... New England Journal of Medicine 378 (13), 1189-1199, 2018 | 757 | 2018 |
| Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms P Lundberg, A Karow, R Nienhold, R Looser, H Hao-Shen, I Nissen, ... Blood, The Journal of the American Society of Hematology 123 (14), 2220-2228, 2014 | 717 | 2014 |
| Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey R Zeiser, A Burchert, C Lengerke, M Verbeek, K Maas-Bauer, ... Leukemia 29 (10), 2062-2068, 2015 | 591 | 2015 |
| Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ... Bone marrow transplantation 51 (6), 786-792, 2016 | 562 | 2016 |
| High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study M Terwijn, WLJ van Putten, A Kelder, VHJ van der Velden, RA Brooimans, ... Journal of clinical oncology 31 (31), 3889-3897, 2013 | 525 | 2013 |
| Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009 P Ljungman, M Bregni, M Brune, J Cornelissen, T De Witte, G Dini, ... Bone marrow transplantation 45 (2), 219-234, 2010 | 504 | 2010 |
| One million haemopoietic stem-cell transplants: a retrospective observational study A Gratwohl, MC Pasquini, M Aljurf, Y Atsuta, H Baldomero, L Foeken, ... The Lancet Haematology 2 (3), e91-e100, 2015 | 467 | 2015 |
| Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European … O Penack, M Marchetti, T Ruutu, M Aljurf, A Bacigalupo, F Bonifazi, ... The Lancet Haematology 7 (2), e157-e167, 2020 | 441 | 2020 |
| Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report JR Passweg, H Baldomero, P Bader, C Bonini, RF Duarte, C Dufour, ... Bone marrow transplantation 52 (6), 811-817, 2017 | 418 | 2017 |
| Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis A Gratwohl, M Stern, R Brand, J Apperley, H Baldomero, T de Witte, ... Cancer 115 (20), 4715-4726, 2009 | 415 | 2009 |
| Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European … A Locasciulli, R Oneto, A Bacigalupo, G Socié, E Korthof, A Bekassy, ... Haematologica 92 (1), 11-18, 2007 | 413 | 2007 |
| Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global … D Niederwieser, H Baldomero, J Szer, M Gratwohl, M Aljurf, Y Atsuta, ... Bone marrow transplantation 51 (6), 778-785, 2016 | 392 | 2016 |
| Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice T Ruutu, A Gratwohl, T De Witte, B Afanasyev, J Apperley, A Bacigalupo, ... Bone marrow transplantation 49 (2), 168-173, 2014 | 391 | 2014 |
| Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy-The European Group for Blood and Marrow Transplantation experience A Bacigalupo, R Brand, R Oneto, B Bruno, G Sodé, J Passweg, ... Seminars in hematology 37 (1), 69-80, 2000 | 385 | 2000 |
| Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel T De Witte, D Bowen, M Robin, L Malcovati, D Niederwieser, ... Blood, The Journal of the American Society of Hematology 129 (13), 1753-1762, 2017 | 376 | 2017 |
